Top 10 at 10: These ASX health and biotech stocks have a spring in their step today

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Respiratory protection manufacturer CleanSpace (ASX:CSX) has been awarded three healthcare distribution contracts for the North American/United States markets.

Collectively, these organisations are part of a critical network of purchasing and distribution channels which service most of the 6,000 hospitals in the U.S – the largest healthcare market in the world.

It is too early to determine what revenue might be generated from these relationships, the company says.

Biotech Argenica Therapeutics (ASX:AGN) has announced positive initial preclinical data on the drug ARG007’s ability to inhibit human recombinant Amyloid-Beta (Abeta) aggregation in a preclinical (in vitro) model of Alzheimer’s Disease.

Abeta aggregation is thought to be one of the main causes of Alzheimer’s Disease.

Kairos Minerals (ASX:KAI) says “outstanding” drilling intersections at the Mt York gold project pave the way for further increases in the 1.1Moz resource.

Latest hits include 5m at 4.25 g/t, 7m at 3.35 g/t and 8m at 3.67 g/t.

And White Cliff Minerals (ASX:WCN) has identified multiple thorium targets at the Yinnetharra REE/Li project.

Thorium anomalies are well documented in the region to potentially be associated with rare earth minerals, it says.

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).